American Academy of Neurology 2007
Boston: Clinical Trial Results for Dimebon Unveiled Boston: Resting State MRI Shows Loss of Network Connectivity Early in AD American Academy of Neurology: 2007 Annual Meeting
6402 RESULTS
Sort By:
Boston: Clinical Trial Results for Dimebon Unveiled Boston: Resting State MRI Shows Loss of Network Connectivity Early in AD American Academy of Neurology: 2007 Annual Meeting
In a randomized, double-blind, placebo-controlled study conducted in Russia,...
One reason to study how brain systems develop is...
NAP, an octapeptide derived from activity-dependent neuroprotective protein (ADNP), reduces...
The twin lesions of Alzheimer disease—amyloid plaques and tau tangles—are mentioned in the same breath but...
Results of a randomized, placebo-controlled clinical trial suggest that coenzyme Q10 (CoQ10)...
No eye-popping action scenes, no happy ending...
A new technique for detecting proteins modified by β-N-acetyl-D-glucosamine (i.e., O-GlcNAc glycosylation) reveals that...
Two papers this week feature inventive strategies for uncovering...
What makes prions adopt toxic, self-perpetuating conformations?...
A new neuron in the adult hippocampus is a bit of a gatecrasher. It must act like...
Amyloid-β (Aβ) precursor protein (APP) has something of a mixed reputation...
A treatment that stops the neurodegenerative process and prevents memory loss is the Holy Grail for Alzheimer disease (AD) researchers...
Genetic association and expression studies have implicated the neuregulin1 growth factor...
The mythical Hydra was virtually indestructible. Lop off one of its many heads, and another would take its place. Chopping off the first two N-terminal amino acids of Aβ1-40/42...
No filters selected